Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP305980.RAqrw2TTCRNZH_bukDv1WCsqQ8V_V-bLXcDKxvlPauWVA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP305980.RAqrw2TTCRNZH_bukDv1WCsqQ8V_V-bLXcDKxvlPauWVA130_assertion type Assertion NP305980.RAqrw2TTCRNZH_bukDv1WCsqQ8V_V-bLXcDKxvlPauWVA130_head.
- NP305980.RAqrw2TTCRNZH_bukDv1WCsqQ8V_V-bLXcDKxvlPauWVA130_assertion description "[After treatments were completed, ELISA method was used to examine the concentration of VEGF-C in plasma and immunohistochemical method to examine microvessel density (MVD), lymphtic vessel density (LVD) of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP305980.RAqrw2TTCRNZH_bukDv1WCsqQ8V_V-bLXcDKxvlPauWVA130_provenance.
- NP305980.RAqrw2TTCRNZH_bukDv1WCsqQ8V_V-bLXcDKxvlPauWVA130_assertion evidence source_evidence_literature NP305980.RAqrw2TTCRNZH_bukDv1WCsqQ8V_V-bLXcDKxvlPauWVA130_provenance.
- NP305980.RAqrw2TTCRNZH_bukDv1WCsqQ8V_V-bLXcDKxvlPauWVA130_assertion SIO_000772 17393109 NP305980.RAqrw2TTCRNZH_bukDv1WCsqQ8V_V-bLXcDKxvlPauWVA130_provenance.
- NP305980.RAqrw2TTCRNZH_bukDv1WCsqQ8V_V-bLXcDKxvlPauWVA130_assertion wasDerivedFrom befree-20140225 NP305980.RAqrw2TTCRNZH_bukDv1WCsqQ8V_V-bLXcDKxvlPauWVA130_provenance.
- NP305980.RAqrw2TTCRNZH_bukDv1WCsqQ8V_V-bLXcDKxvlPauWVA130_assertion wasGeneratedBy ECO_0000203 NP305980.RAqrw2TTCRNZH_bukDv1WCsqQ8V_V-bLXcDKxvlPauWVA130_provenance.